Alu methylation serves as a biomarker for non-invasive diagnosis of glioma

Current techniques for diagnosing glioma are invasive and do not accurately predict prognosis. We developed a novel, non-invasive liquid chip assay to diagnose glioma and predict prognosis. Using this method, we determined the methylation state of the Alu element in cell-free DNA extracted from the serum of 109 glioma patients. Controls included 56 patients with benign intracranial tumors and 50 healthy subjects. Matched tumor tissues were processed for 36 patients. The cfDNA from glioma patients showed lower levels of Alu methylation than the controls (P<0.01). Alu methylation was also lower in high-grade than low-grade gliomas (P<0.01), indicating that Alu methylation correlates negatively with disease severity. Moreover, Alu methylation correlated positively with survival (P<0.01). These findings suggest high-throughput liquid chip could serve as a non-invasive diagnostic assay for glioma.

[1]  T. Siegal,et al.  Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades. , 2010, Neuro-oncology.

[2]  J. Tonn,et al.  Extraneural Metastases of Primary Brain Tumors , 2001, Journal of Neuro-Oncology.

[3]  S. Kochanek,et al.  DNA methylation in the Alu sequences of diploid and haploid primary human cells. , 1993, The EMBO journal.

[4]  M. Fraga,et al.  Global DNA hypomethylation in cancer: review of validated methods and clinical significance , 2012, Clinical chemistry and laboratory medicine.

[5]  A. Bardelli,et al.  Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities. , 2014, Cancer treatment reviews.

[6]  M. Esteller,et al.  DNA methylation and cancer. , 2010, Advances in genetics.

[7]  Alexander R. Pico,et al.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.

[8]  R. Guleria,et al.  Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. , 2006, Clinical chemistry.

[9]  Xiujie Wu,et al.  Prognostic Value of Free DNA Quantification in Serum and Cerebrospinal Fluid in Glioma Patients , 2011, Journal of Molecular Neuroscience.

[10]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[11]  S. Dunbar.  Applications of Luminex® xMAP™ technology for rapid, high-throughput multiplexed nucleic acid detection , 2005, Clinica Chimica Acta.

[12]  P. Deininger,et al.  Alu elements: an intrinsic source of human genome instability. , 2013, Current opinion in virology.

[13]  S. Cha,et al.  Update on brain tumor imaging: from anatomy to physiology. , 2006, AJNR. American journal of neuroradiology.

[14]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[15]  D. Hoon,et al.  Higher Amount of Free Circulating DNA in Serum than in Plasma Is Not Mainly Caused by Contaminated Extraneous DNA during Separation , 2006, Annals of the New York Academy of Sciences.

[16]  S. Ju,et al.  Recent advances in clinical applications of circulating cell-free DNA integrity. , 2014, Laboratory medicine.

[17]  K. Nie,et al.  Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer , 2014, Tumor Biology.

[18]  M. Ehrlich,et al.  The 5-methylcytosine content of highly repeated sequences in human DNA. , 1983, Nucleic acids research.

[19]  D. Hoon,et al.  Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients , 2013, Expert review of molecular diagnostics.

[20]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[21]  G. Kristiansen,et al.  Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies , 2014, Critical reviews in clinical laboratory sciences.

[22]  D. Davies,et al.  Blood–brain barrier breakdown in septic encephalopathy and brain tumours * , 2002, Journal of anatomy.

[23]  Christian B. Woods,et al.  Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.

[24]  M. Speicher,et al.  Hematogenous dissemination of glioblastoma multiforme , 2014, Science Translational Medicine.

[25]  V. Vlassov,et al.  Circulating nucleic acids as a potential source for cancer biomarkers. , 2010, Current molecular medicine.

[26]  A. Kalmár,et al.  Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA , 2014, PloS one.